Significance of upper paratracheal lymph node resection in stage IB right lung cancer

Author:

Wang Feng1,Yu Xiangyang2,Han Yi1,Zhang Lanjun3,Liu Shuku1

Affiliation:

1. Beijing Chest Hospital, Capital Medical University; Beijing Tuberculosis and Thoracic Tumor Research Institute

2. National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

3. State Key Laboratory of Oncology in South China, Department of Thoracic Surgery, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center

Abstract

Abstract Objective The aim of this study was to investigate the effect of upper paratracheal lymph node (2R lymph node) resection on the prognosis of stage IB right lung cancer Methods We retrospectively collected data of 339 patients with stage IB right lung cancer who underwent radical surgery from 1999 to 2009. The prognostic factors were evaluated by Cox proportional hazard regression model. Propensity score matching (PSM) was applied to adjust the confounding factors. The Kaplan-Meier method was applied to evaluate overall survival (OS) and recurrence-free survival (RFS). Results For all 339 cases included in the study, Univariate and multivariate analysis showed that smoking and family history of malignant tumors were prognostic factors for OS. Age and family history of malignant tumors were prognostic factors for RFS. Resection of the 2R lymph node was not statistically associated with OS and RFS. All cases were separated into two groups based on whether the 2R lymph nodes were resected. The results of survival analysis after PSM also suggest that the resection of 2R lymph node is not statistically associated with OS and RFS (P > 0.05). Conclusions For stage IB right lung cancer, upper paratracheal lymph node resection was not statistically associated with OS or RFS. 2R lymph node resection may not be necessary for early-stage NSCLC.

Publisher

Research Square Platform LLC

Reference30 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

2. Lung cancer;Herbst RS;N Engl J Med,2008

3. European trends in preoperative and intraoperative nodal staging: ESTS guidelines;Leyn P;J Thorac Oncol,2007

4. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Howington JA;Chest,2013

5. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study;Abughararah TZ;Eur J Cardiothorac Surg,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3